XS
PFE icon

XR Securities’s Pfizer PFE Stock Holding History

XR Securities’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-9,800
Closed -$502K – 520
2022
Q4 		$502K Sell
9,800
-3,000
-23% -$144K 0.05% 278
2022
Q3 		$12K Sell
12,800
-22,000
-63% -$1.07M 0.01% 314
2022
Q2 		$107K Buy
34,800
+15,700
+82% +$800K 0.04% 209
2022
Q1 		$77K Sell
19,100
-35,100
-65% -$1.82M 0.01% 216
2021
Q4 		$551K Buy
54,200
+43,900
+426% +$2.18M 0.05% 87
2021
Q3 		$19K Sell
10,300
-10,600
-51% -$470K 0.01% 344
2021
Q2 		$17K Sell
20,900
-9,700
-32% -$377K 0.01% 374
2021
Q1 		$12K Sell
30,600
-58,200
-66% -$2.07M ﹤0.01% 422
2020
Q4 		$100K Buy
88,800
+70,671
+390% +$2.59M 0.01% 247
2020
Q3 		$25K Buy
18,129
+4,849
+37% +$170K ﹤0.01% 216
2020
Q2 		$10K Buy
+13,280
New +$451K ﹤0.01% 226

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

XR Securities's PFE Position: Q3 2024 in Review

XR Securities sold out of Pfizer (PFE) in Q3 2024, closing a stake of 7,794 shares — an estimated $227K sold.

XR Securities first reported a position in PFE in Q2 2020 and held it in 9 quarters. The position peaked at $1.36M in Q1 2021. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

  • XR Securities reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
  • XR Securities sold 7,794 Pfizer shares in Q3 2024, an estimated $227K.
  • XR Securities first reported a position in Pfizer in Q2 2020 and held it in 9 quarters.
  • XR Securities's Pfizer position peaked at $1.36M in Q1 2021.
  • 2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on XR Securities's 13F filing for Q3 2024, filed 25 Oct 2024.